Results 221 to 230 of about 54,569 (261)

From Marginal to Central: Marginal Zone‐like B Cells as Critical Targets in Cladribine‐Treated Multiple Sclerosis

open access: yesAnnals of Neurology, EarlyView.
Objective Multiple sclerosis (MS) is a chronic autoimmune disease where B cells play a central pathogenic role. Cladribine, an oral therapy, provides durable benefits by reshaping lymphocyte populations, yet its specific long‐term impact on distinct B‐cell subsets is not fully understood.
Marta Pirronello   +20 more
wiley   +1 more source

Immunogenic cell death as a cornerstone for combination therapies with immune checkpoint blockade. [PDF]

open access: yesMol Cancer
Niu Y   +10 more
europepmc   +1 more source

A multi-epitope vaccine targeting a key virulence factor ClfA: An In-silico approach to combat Staphylococcus aureus infections. [PDF]

open access: yesPLoS One
Nirob MNH   +8 more
europepmc   +1 more source

Bronchus-associated lymphoid tissue: a review of its development and function, including recent findings on the impact of environmental particulate exposure. [PDF]

open access: yesClin Exp Med
Mikami Y   +10 more
europepmc   +1 more source

Chemoattractant lymphokines specific for the helper/inducer T-lymphocyte subset

open access: yesCellular Immunology, 1985
The cellular content of T-lymphocyte-rich inflammatory sites is dependent in part on the in situ elaboration of chemoattractant factors. We have previously described three T-lymphocyte-specific chemoattractant lymphokines; a chemokinetic factor, lymphocyte chemoattractant factor (LCF, MW 56,000), and two distinct lymphocyte migration inhibitory factors
J S, Berman   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy